drugset / Trial / NCT00864058
A Relative Bioavailability Study of Gabapentin 400 mg Capsules Under Fasting Conditions
RandomizedCrossoverOpen-label
Summary
To compare the relative bioavailability of gabapentin 400 mg capsules (Purepac) with that of NEURONTIN® 400 mg capsules (Parke-Davis) in healthy adult male subjects under fasting conditions
Timeline
- Start
- 1998-01
- Primary completion
- 1998-01
- Completion
- 1998-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gabapentin | Small molecule | 400 mg | — |
Indications
No indication recorded.